World Wires · story 20790 · unverified · 1 source(s)

Harrow Closes Acquisition of TYRVAYA®

First and Only FDA-Approved Nasal Spray for Dry Eye Disease Adds a Differentiated, Drop-Free Treatment Option to Harrow’s Growing Ocular Surface Franchise

Open in the desk

Coverage

• Harrow Closes Acquisition of TYRVAYA® GlobeNewswire: public companies · tier D · clear net · 2026-10-05 11:00 UTC

What this site indexes